{"id":"https://openalex.org/W1968338902","doi":"https://doi.org/10.1517/17425240802542690","title":"Use of rivastigmine transdermal patch in the treatment of Alzheimer's disease","display_name":"Use of rivastigmine transdermal patch in the treatment of Alzheimer's disease","alternate_titles":[],"publication_year":2008,"publication_date":"2008-11-14","ids":{"openalex":"https://openalex.org/W1968338902","doi":"https://doi.org/10.1517/17425240802542690","mag":"1968338902","pmid":"https://pubmed.ncbi.nlm.nih.gov/19040398"},"language":"en","primary_location":{"id":"doi:10.1517/17425240802542690","doi":"https://doi.org/10.1517/17425240802542690","is_oa":false,"landing_page_url":"https://doi.org/10.1517/17425240802542690","pdf_url":null,"source":{"id":"https://openalex.org/S51663496","display_name":"Expert Opinion on Drug Delivery","issn_l":"1742-5247","issn":["1742-5247","1744-7593"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Delivery","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1968338902"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081283156","display_name":"Bengt G. Winblad","orcid":"https://orcid.org/0000-0002-0011-1179","observed_orcids":["https://orcid.org/0000-0002-0011-1179"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bengt Winblad","raw_affiliation_strings":["Karolinska Institutet Alzheimer's Disease Research Center (KI-ADRC), Floor 5, S-14157, NOVUM, Huddinge, Sweden. Bengt.Winblad@ki.se","Professor Karolinska Institutet Alzheimer's Disease Research Center (KI-ADRC), Floor 5, S-14157, NOVUM, Huddinge, Sweden +46 8 585 85 474"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karolinska Institutet Alzheimer's Disease Research Center (KI-ADRC), Floor 5, S-14157, NOVUM, Huddinge, Sweden. Bengt.Winblad@ki.se","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Professor Karolinska Institutet Alzheimer's Disease Research Center (KI-ADRC), Floor 5, S-14157, NOVUM, Huddinge, Sweden +46 8 585 85 474","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"last","author":{"id":null,"display_name":"Jo\u00e3o Carlos Machado","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163733","display_name":"Mater Dei Hospital","ror":"https://ror.org/05ybvz010","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210163733"]}],"countries":["BR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jo\u00e3o Carlos Machado","raw_affiliation_strings":["Clinical Director Aurus \u2013 Institute of Geriatric Medicine and Gerontology, Mater Dei Hospital Faculty of Medical Sciences of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Director Aurus \u2013 Institute of Geriatric Medicine and Gerontology, Mater Dei Hospital Faculty of Medical Sciences of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil","institution_ids":["https://openalex.org/I4210163733"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.8757,"has_fulltext":false,"cited_by_count":77,"citation_normalized_percentile":{"value":0.92292933,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"5","issue":"12","first_page":"1377","last_page":"1386"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.023800000548362732,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.008500000461935997,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rivastigmine","display_name":"rivastigmine","score":0.9900000095367432},{"id":"https://openalex.org/keywords/transdermal-patch","display_name":"transdermal patch","score":0.9980000257492065},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.9890000224113464},{"id":"https://openalex.org/keywords/transdermal-drug-delivery","display_name":"transdermal drug delivery","score":0.8270000219345093},{"id":"https://openalex.org/keywords/continuous-drug-delivery","display_name":"continuous drug delivery","score":0.7630000114440918},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.7450000047683716},{"id":"https://openalex.org/keywords/nausea-and-vomiting","display_name":"nausea and vomiting","score":0.7699999809265137},{"id":"https://openalex.org/keywords/skin-tolerability","display_name":"skin tolerability","score":0.9110000133514404},{"id":"https://openalex.org/keywords/patch-adhesion","display_name":"patch adhesion","score":0.9570000171661377},{"id":"https://openalex.org/keywords/patient-acceptability","display_name":"patient acceptability","score":0.8190000057220459},{"id":"https://openalex.org/keywords/dementia-treatment","display_name":"dementia treatment","score":0.6480000019073486}],"concepts":[{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.9823741912841797},{"id":"https://openalex.org/C2775842315","wikidata":"https://www.wikidata.org/wiki/Q1145270","display_name":"Transdermal patch","level":3,"score":0.8698009252548218},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7337546944618225},{"id":"https://openalex.org/C205679159","wikidata":"https://www.wikidata.org/wiki/Q3375179","display_name":"Transdermal","level":2,"score":0.7069198489189148},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.606386661529541},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5867529511451721},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5826383233070374},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.47375208139419556},{"id":"https://openalex.org/C31896038","wikidata":"https://www.wikidata.org/wiki/Q415635","display_name":"Cholinesterase","level":2,"score":0.4376709461212158},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3897678852081299},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3152483105659485},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.24576181173324585},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22831305861473083},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.15861880779266357}],"mesh":[{"descriptor_ui":"D000068836","descriptor_name":"Rivastigmine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012869","descriptor_name":"Skin Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048448","descriptor_name":"Phenylcarbamates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D048448","descriptor_name":"Phenylcarbamates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1517/17425240802542690","doi":"https://doi.org/10.1517/17425240802542690","is_oa":false,"landing_page_url":"https://doi.org/10.1517/17425240802542690","pdf_url":null,"source":{"id":"https://openalex.org/S51663496","display_name":"Expert Opinion on Drug Delivery","issn_l":"1742-5247","issn":["1742-5247","1744-7593"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Delivery","raw_type":"journal-article"},{"id":"pmid:19040398","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19040398","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on drug delivery","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W167744726","https://openalex.org/W170237590","https://openalex.org/W581657805","https://openalex.org/W1492322205","https://openalex.org/W1504356022","https://openalex.org/W1587061890","https://openalex.org/W1978708350","https://openalex.org/W1987624864","https://openalex.org/W1995860586","https://openalex.org/W2004305668","https://openalex.org/W2006734683","https://openalex.org/W2016149437","https://openalex.org/W2024623973","https://openalex.org/W2030817295","https://openalex.org/W2045413014","https://openalex.org/W2050009016","https://openalex.org/W2051925617","https://openalex.org/W2052011640","https://openalex.org/W2057679568","https://openalex.org/W2062329194","https://openalex.org/W2064511862","https://openalex.org/W2067207334","https://openalex.org/W2079725819","https://openalex.org/W2081159973","https://openalex.org/W2106585418","https://openalex.org/W2119046925","https://openalex.org/W2124214873","https://openalex.org/W2133901332","https://openalex.org/W2151930795","https://openalex.org/W2160552877","https://openalex.org/W2232925942","https://openalex.org/W2396951956","https://openalex.org/W2414565701"],"related_works":["https://openalex.org/W2034596923","https://openalex.org/W1993825148","https://openalex.org/W2134043280","https://openalex.org/W2012483918","https://openalex.org/W2124214873","https://openalex.org/W1646381273","https://openalex.org/W2359081310","https://openalex.org/W7092181482","https://openalex.org/W1751954123","https://openalex.org/W2300808102"],"abstract_inverted_index":{"Cholinesterase":[0],"inhibitors":[1],"such":[2],"as":[3],"rivastigmine":[4,54,66,82,112,120,135,163],"and":[5,41,51,74,91,131,139,152,170],"donepezil":[6],"exhibit":[7],"a":[8,48,85,92],"dose-response":[9],"relationship,":[10],"with":[11,27,44,124],"higher":[12],"doses":[13],"of":[14,34,87,95,129,162,167,181],"the":[15,28,39,65,106,118,134,153,178],"drugs":[16],"demonstrating":[17],"greater":[18],"efficacy.":[19,145],"Transdermal":[20],"patches":[21],"provide":[22],"smooth":[23],"continuous":[24],"drug":[25,35],"delivery,":[26],"potential":[29],"to":[30,59,70,117,142],"offer":[31],"efficacious":[32],"levels":[33],"exposure":[36],"while":[37],"avoiding":[38],"peaks":[40],"troughs":[42],"associated":[43],"side":[45],"effects.":[46],"As":[47],"small,":[49],"lipophilic":[50],"hydrophilic":[52],"molecule,":[53],"(C14H22N2O2)":[55],"is":[56,150],"chemically":[57],"well-suited":[58],"transdermal":[60],"delivery.":[61],"The":[62,76,146,159],"technology":[63],"underlying":[64],"patch":[67,83,113,136,154],"allows":[68],"it":[69,175],"be":[71],"discreetly":[72],"small":[73],"thin.":[75],"target":[77,107],"dose":[78,108,144],"9.5":[79,109],"mg/24":[80,110],"h":[81,111],"has":[84,103,155],"diameter":[86],"just":[88],"3.5":[89],"cm":[90],"surface":[93],"area":[94],"10":[96],"cm2.":[97],"A":[98],"large":[99],"randomized":[100],"controlled":[101],"trial":[102],"demonstrated":[104,156],"that":[105,174],"provided":[114],"similar":[115],"efficacy":[116],"highest":[119],"capsule":[121],"doses,":[122],"yet":[123],"three":[125],"times":[126],"fewer":[127],"reports":[128],"nausea":[130],"vomiting.":[132],"Thus,":[133],"enables":[137],"quick":[138],"easy":[140],"access":[141],"high":[143],"skin":[147],"tolerability":[148],"profile":[149],"good,":[151],"excellent":[157],"adhesion.":[158],"apparent":[160],"success":[161],"patch,":[164],"in":[165],"terms":[166],"clinical":[168],"utility":[169],"patient":[171],"acceptability,":[172],"suggests":[173],"may":[176],"mark":[177],"next":[179],"generation":[180],"dementia":[182],"treatment.":[183]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1968338902","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
